A Sharpe ratio of 2.0 on 18 months of data proves almost nothing. Minimum Track Record Length turns “impressive Sharpe” into “how many years would this take to believe” — with the numbers.
A strategy shows a Sharpe ratio of 2.0. Your instinct says “excellent.” The correct response is a question: over how long?
Minimum Track Record Length (MinTRL) is the answer to that question, formalised. It asks: given an observed Sharpe ratio, how many years of track record would you need before you could believe, with 95% confidence, that the true Sharpe is above zero — that the strategy is better than nothing at all?
The idea comes from the same research tradition as the deflated Sharpe ratio (Bailey and López de Prado), and it is brutally clarifying, because it converts a sexy number into a boring one: years.
Why short track records prove so little
Returns are noisy. A high Sharpe over a short window can easily be luck — a few good months, a favourable regime, a lucky draw. The shorter the window, the wider the uncertainty around the Sharpe, and the longer the track record you would need to shrink that uncertainty to something believable.
The relationship runs the way you would hope it does not: the more modest the Sharpe, the longer the record needed. As an anchored example from the reference literature, a Sharpe of around 0.95 on daily data needs roughly 3 years of history to clear the 95% confidence bar. Lower Sharpes need longer; higher Sharpes need less — but even a Sharpe of 2.0 on a year and a half of data is thinner evidence than it looks, and once you correct for the number of strategies tried (the multiple-testing problem), the required length grows further. In some published multi-market reviews, the required length for the observed Sharpes was effectively infinite — the data could not support the claim at any reasonable horizon.
The trial-count trap inside MinTRL
Here is the part vendors never mention: MinTRL assumes the Sharpe you see is the Sharpe of one strategy, honestly measured. If the vendor tried 200 strategies and shows you the best, the relevant Sharpe is deflated first — and the deflated Sharpe needs a longer track record than the advertised one. A Sharpe of 2.0 that deflates to 0.6 under a multiple-testing correction does not need months of belief. It needs years.
So the two questions always travel together: “What is the Sharpe?” and “How many did you try?” A MinTRL quoted without a trial count is a half-answer.
How to use MinTRL tomorrow
When a vendor quotes a Sharpe, ask for the track record length in years and the number of trials. Then ask what MinTRL their own numbers imply. If they cannot answer, they have not done this math — and you should do it for them, conservatively.
Treat any Sharpe above 3.0 on a short record as a red flag, not a selling point. Extreme Sharpes on short samples are the signature of overfitting, not genius.
Remember that MinTRL is about statistical belief, not profitability. A strategy can clear MinTRL and still lose money to costs, slippage, and regime change. It is one gate among several: recompute, baselines, walk-forward folds, leakage, trial correction, and then track-record length.
The honest summary: most strategies you are shown have not existed long enough, on their own numbers, to be believed. MinTRL just makes that sentence quantitative — and once you see it in years, you cannot unsee it.
A Sharpe of 2.0 on 18 months is a claim. A Sharpe of 2.0 on 5 years with a known trial count is evidence. MinTRL turns the first into the second.
This article is educational, not financial advice. Past backtest results do not predict future returns.
Top comments (0)